Share the Science: Dr. John Wagner - Combatting GvHD with Cord Blood

Save the Cord Foundation and WellSky are proud to welcome Dr. John Wagner, as our featured speaker for our next edition of Share the Science on July 22nd, 2021 2pm ET / 11am PT. Join us to hear Dr. Wagner discuss his research using umbilical cord blood-derived regulatory T Cells (Tregs) to combat Graft versus Host Disease (GvHD). RECORDING NOW AVAILABLE.
​
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Preventing GvHD with Regulatory T Cells (Tregs)

Join us to hear pioneering researcher John Wagner, M.D. as he shares some of his latest work involving potential treatment of autoimmunity and graft-versus-host disease (GVHD).

Infection and relapse are the principal obstacles to successful use of allogeneic hematopoietic stem cell transplantation. Prolonged immunodeficiency is a major cause of infection and relapse, particularly in those with high-risk disease, older age, use of in vivo and ex vivo T cell depletion, HLA mismatch, and after the development of acute and chronic GVHD.

Trials have demonstrated that the infusion of umbilical cord blood (UCB) derived regulatory T cells (Tregs) could effectively prevent GVHD. Join Dr. Wagner as he also shares how thymic progenitor cells (Pro-Ts) can repair damaged immune systems, and how UCB can reliably provide large numbers of Pro-Ts suitable for clinical use.

SHARE THE SCIENCE
with

John Wagner, M.D.

Founding Director of the Institute of Cell, Gene and Immunotherapeutics
​at the University of Minnesota
 
"Combatting GVHD with UCB-derived regulatory T cells"

Free webinar.  Open to the public.
​
Thursday, July 22nd at 2 pm ET / 11am PT

RECORDING NOW AVAILABLE

Register Here: Share the Science - Dr. John Wagner - Combatting GvHD with UCB-derived T Cells

About the speaker

Dr. John Wagner

Founding Director of the Institute of Cell, Gene and Immunotherapeutics at the University of Minnesota

Dr. Wagner's research is focused on the development of novel cell therapies for treatment of life threatening diseases. Examples include the development of regulatory T cells that could be used in the treatment of autoimmunity, organ graft rejection as well as graft-versus-host disease, thymic progenitors to repair damaged immune systems, cardiac myoblasts to reverse heart failure, skeletal myoblasts to repair or replace dystrophic muscle fibers in muscular dystrophy, and expansion of the blood-forming stem cell to speed blood and marrow recovery after high doses of chemotherapy and radiation.

Dr. Wagner is best known for his pioneering work on the use of placental/cord blood as a source of stem cells for transplantation – a procedure that has now been performed in more than 50,000 patients worldwide.

---

We wish to thank Dr. John Wagner for volunteering his time to speak on
Share the Science and sharing his valuable insight
on the use of cord blood-derived Tcells (Tregs) to combat GvHD.
​​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.